Description: The most recent U.S. population data released by the Centers for Disease Control and Prevention (CDC) and from the U.S. Census at year-end 2021 includes the first ten months of the COVID-19 pandemic in the U.S. While we know the pandemic has had significant impacts on both the U.S. population and insured population mortality, we also see increased mortality due to many other non-COVID causes of death. Where are the biggest changes and what does this non-COVID excess mortality mean over the next few years? Take part as an expert panel hosts an interactive discussion to examine data from general population as well as from both individual life and group life experience studies to explore how these changes might spur innovation in underwriting, assumption setting and pricing.

Description: ClubVita Session Series Buyouts and indemnity swaps remove all the longevity risk from an underlying population. However, they can be difficult to unwind and are not very flexible or widely tradable. Explore the characteristics and product structures of indexed based longevity swaps, demonstrating how they can cover any term, how they hedge the key component of trend risk and how, with new technology developments, they could lead to a liquid market.

Description: Emerging risks are new or evolving, so require novel treatment by risk teams. The results from the 15th annual survey of emerging risks, sponsored by the Canadian Institute of Actuaries (CIA), Society of Actuaries (SOA) and Casualty Actuarial Society (CAS) will be shared. Long-term trends and highlights from open-ended questions will be shared, along with analysis of how the practitioner can use this information. While risk appetite statements profess a stable and consistent process, research shows that companies rotate through methodologies with management teams and that the most successful teams have the flexibility to adjust to current conditions.

Description: While the higher general inflation in the broader U.S. economy hasn't emerged in the healthcare market (yet); there is expectations for it to have a lagged impact especially as the full impact of COVID on suppressed utilization emerges. As the healthcare system transitions past COVID, overall costs are expected to trend higher due to overall inflationary pressures as well as new treatments such as the highly anticipated new gene and cell therapies often with costs over millions of dollars.As costs rise, more companies are looking to self-insure their health insurance to control cost increases and are leveraging innovative stop loss programs including captives. Captive insurance markets have seen significant growth and diverse implementations allowing companies to self-fund while managing the risk of large claims and increasing costs. Payers are also looking to control costs and implement value based payment schemes to bend the trend curve and manage costs. Medicare has also adopted new value based payment programs (ACO Reach) which will impact commercial payers and are important to understand. Come gain an understanding of the historical and projected future medical cost drivers including the projected impact of new therapies and then impact on the stop loss markets. Additionally, you'll gain a deeper understanding on how recent innovations in the stop loss market such as the growth in the captive market, level funded and aggregate only products have helped employers manage their costs and overall risk profile.

Description: The National Association of Insurance Commissioners (NAIC) is working on changes to the health risk-based capital (RBC) formula. Will your RBC ratio improve or deteriorate under the new formula? And what can you do about it?

Description: The insurance industry hinges on accurate actuarial assumptions. This session explores how insurers can leverage AI/machine learning (ML) to unlock greater accuracy and granularity in assumption setting, while effectively managing risks, implementing strong governance frameworks, and meeting validation expectations from regulators.

Description: Welcome to the appellate court. We’ve seen some scare in mass media on climate-linked mortality, but not sure what to make of that in our actuarial practice. Both data and research is quickly evolving around climate change’s impact globally and to US mortality. We’ll share a few tidbits from recent actuarial research on wildfires and air pollution in particular. At the same time, there are still many unknowns on the long-term effects, and this phase of understanding is ripe for calling on a diverse group of experts. We bring expert witnesses from different professions to the actuarial stand to answer whether climate change’s impacts from heat wildfire-induced air pollution to mental health is a credible and material threat to insured mortality. The audience should come ready to judge the arguments presented.

Description: Session 3G: Enhancing ERM - Practical Applications of ASOP 46 and ASOP 47

Description: ALM actuaries are critical to insurance companies and pension funds—monitoring ALM positioning, measuring risk exposures, and informing the investment decision making process. However, there are opportunities for actuaries to further increase their impact by expanding their scope and embedding actuarial expertise throughout the investment lifecycle. This session will cover new and enhanced ALM techniques to improve ALM risk and return outcomes, including better integration of credit and market risk measurement, and enhanced liability-driven investing strategies.

Description: Learn from panelists from different companies as they come together to discuss their experiences.